keyword
https://read.qxmd.com/read/38687870/tumor-budding-as-a-risk-factor-for-lymph-node-metastases-in-cutaneous-squamous-cell-carcinoma-a-systematic-review-and-meta-analysis
#41
JOURNAL ARTICLE
Pedro Gil-Pallares, Maria Eugenia Gil-Pallares, Alba Navarro-Bielsa, Olalla Figueroa-Silva, Laura Taboada-Paz, José Manuel Suárez-Peñaranda
BACKGROUND: Current staging systems have limitations in stratifying high-risk cases of cutaneous squamous cell carcinoma (cSCC). Tumor budding (TB) has emerged as a potential prognostic factor in various cancers. OBJECTIVES: This systematic review and meta-analysis aimed to evaluate the prognostic significance of TB in predicting lymph node metastases (NM) in cSCC. METHODS: A comprehensive search of the PubMed, Web of Science, EMBASE, and Cochrane databases was conducted...
April 30, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38687868/cancercelllines-org-a-novel-resource-for-genomic-variants-in-cancer-cell-lines
#42
JOURNAL ARTICLE
Rahel Paloots, Michael Baudis
Cancer cell lines are an important component in biological and medical research, enabling studies of cellular mechanisms as well as the development and testing of pharmaceuticals. Genomic alterations in cancer cell lines are widely studied as models for oncogenetic events and are represented in a wide range of primary resources. We have created a comprehensive, curated knowledge resource-cancercelllines.org-with the aim to enable easy access to genomic profiling data in cancer cell lines, curated from a variety of resources and integrating both copy number and single nucleotide variants data...
April 30, 2024: Database: the Journal of Biological Databases and Curation
https://read.qxmd.com/read/38687862/efficacy-of-breast-conserving-surgery-versus-modified-radical-surgery-in-the-treatment-of-early-breast-cancer-a-meta-analysis
#43
JOURNAL ARTICLE
Tao Li, Peng Zhang, Yantao Zhang, Jun Qi, Yong Sun, Bin Lu
OBJECTIVE: The study aims to assess and compare the outcomes of modified radical surgery, preserving the nipple-areola complex, against radical mastectomy in patients with triple-negative breast cancer. Emphasis is placed on the clinical significance of this comparison, including its potential impact on patient outcomes, quality of life, and healthcare resources. METHODS: Relevant literature from January 2017 to January 2022 was searched in the following databases: PubMed, Embase, MEDLINE, Science Citation Index, Web of Science, China National Knowledge Internet, CCD, and CSPD with keywords...
April 26, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38687849/effect-of-nlrp3-inflammasome-on-lung-cancer-immune-microenvironment-activation-and-its-mechanism
#44
JOURNAL ARTICLE
Zhaoxun Li, Fujun Yang, Xinsheng Zhu, Bin Zhou, Kaiqi Jin, Jie Dai, Gening Jiang
OBJECTIVE: The NLRP3 inflammasome plays a dual role in the occurrence and development of tumors, and its role in lung cancer remains unclear. This study aims to investigate the impact of NLRP3 inflammasome activation on the proliferation and migration of lung cancer cells. METHODS: Data from the GEPIA, TCGA, and HPA databases were utilized to analyze the expression of NLRP3 in lung adenocarcinoma and its microenvironment. GO/KEGG enrichment analysis and GSEA analysis were employed to annotate the functions of differentially expressed genes related to NLRP3...
April 26, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38687844/aapa-talks-with-uspstf-about-its-new-breast-cancer-screening-recommendation
#45
JOURNAL ARTICLE
Wanda Nicholson, Annamarie F Streilein
No abstract text is available yet for this article.
May 1, 2024: JAAPA: Official Journal of the American Academy of Physician Assistants
https://read.qxmd.com/read/38687830/preventable-premature-deaths-from-the-five-leading-causes-of-death-in-nonmetropolitan-and-metropolitan-counties-united-states-2010-2022
#46
JOURNAL ARTICLE
Macarena C García, Lauren M Rossen, Kevin Matthews, Gery Guy, Katrina F Trivers, Cheryll C Thomas, Linda Schieb, Michael F Iademarco
PROBLEM/CONDITION: A 2019 report quantified the higher percentage of potentially excess (preventable) deaths in U.S. nonmetropolitan areas compared with metropolitan areas during 2010-2017. In that report, CDC compared national, regional, and state estimates of preventable premature deaths from the five leading causes of death in nonmetropolitan and metropolitan counties during 2010-2017. This report provides estimates of preventable premature deaths for additional years (2010-2022). PERIOD COVERED: 2010-2022...
May 2, 2024: MMWR Surveillance Summaries
https://read.qxmd.com/read/38687804/synergistic-epistasis-among-cancer-drivers-can-rescue-early-tumors-from-the-accumulation-of-deleterious-passengers
#47
JOURNAL ARTICLE
Carla Alejandre, Jorge Calle-Espinosa, Jaime Iranzo
Epistasis among driver mutations is pervasive and explains relevant features of cancer, such as differential therapy response and convergence towards well-characterized molecular subtypes. Furthermore, a growing body of evidence suggests that tumor development could be hampered by the accumulation of slightly deleterious passenger mutations. In this work, we combined empirical epistasis networks, computer simulations, and mathematical models to explore how synergistic interactions among driver mutations affect cancer progression under the burden of slightly deleterious passengers...
April 30, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38687802/leveraging-genomic-signatures-of-oral-microbiome-associated-antibiotic-resistance-genes-for-diagnosing-pancreatic-cancer
#48
JOURNAL ARTICLE
Xiaojing Shen, Xiaolin Zhu, Hairong Liu, Rongtao Yuan, Qingyuan Guo, Peng Zhao
Growing evidence has increasingly suggested a potential linkage between the oral microbiome and various diseases, including pancreatic ductal adenocarcinoma (PDAC). However, the utilization of gene-level information derived from the oral microbiome for diagnosing PDAC remains unexplored. In this study, we sought to investigate the novel potential of leveraging genomic signatures associated with antibiotic resistance genes (ARGs) within the oral microbiome for the diagnosis of PDAC. By conducting an analysis of oral microbiome samples obtained from PDAC patients, we successfully identified specific ARGs that displayed distinct sequence abundance profiles correlated with the presence of PDAC...
2024: PloS One
https://read.qxmd.com/read/38687769/emerging-roles-of-long-non-coding-rnas-in-human-epilepsy
#49
REVIEW
Fatemeh Yazarlou, Leonard Lipovich, Jeffrey A Loeb
Genome-scale biological studies conducted in the post-genomic era have revealed that two-thirds of human genes do not encode proteins. Most functional non-coding RNA transcripts in humans are products of long non-coding RNA (lncRNA) genes, an abundant but still poorly understood class of human genes. As a result of their fundamental and multitasking regulatory roles, lncRNAs are associated with a wide range of human diseases, including neurological disorders. Approximately 40% of lncRNAs are specifically expressed in the brain, and many of them exhibit distinct spatiotemporal patterns of expression...
April 30, 2024: Epilepsia
https://read.qxmd.com/read/38687753/the-association-of-egfr-amplification-with-aberrant-exon-20-insertion-report-using-the-cobas-egfr-mutation-test-v2
#50
JOURNAL ARTICLE
Man-San Zhang, Yi-Chen Yeh, Hsien-Neng Huang, Long-Wei Lin, Yen-Lin Huang, Lei-Chi Wang, Lai-Jin Yao, Tze-Chun Hung, Yu-Fen Tseng, Yi-Hsuan Lee, Wei-Yu Liao, Jin-Yuan Shih, Min-Shu Hsieh
Determining the exact type of epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutation in lung cancer has become important. We found that not all ex20ins mutations reported by cobas EGFR test v2 could be validated by Sanger sequencing even using surgical specimens with high tumor contents. This study aimed to validate the ex20ins results reported by the cobas test and to determine whether there were clinicopathological factors associated with aberrant cobas ex20ins report. In total, 123 cobas-reported cases with ex20ins were retrospectively collected and validated by Sanger sequencing and Idylla assay...
2024: PloS One
https://read.qxmd.com/read/38687749/ph-responsive-targeted-nanoparticles-release-erk-inhibitor-in-the-hypoxic-zone-and-sensitize-free-gemcitabine-in-mutant-k-ras-addicted-pancreatic-cancer-cells-and-mouse-model
#51
JOURNAL ARTICLE
Debasmita Dutta, Priyanka Ray, Archana De, Arnab Ghosh, Raj Shankar Hazra, Pratyusha Ghosh, Snigdha Banerjee, Francisco J Diaz, Sunil P Upadhyay, Mohiuddin Quadir, Sushanta K Banerjee
Therapeutic options for managing Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of aggressive malignancies, are limited and disappointing. Therefore, despite suboptimal clinical effects, gemcitabine (GEM) remains the first-line chemotherapeutic drug in the clinic for PDAC treatment. The therapeutic limitations of GEM are primarily due to poor bioavailability and the development of chemoresistance resulting from the addiction of mutant-K-RAS/AKT/ERK signaling-mediated desmoplastic barriers with a hypoxic microenvironment...
2024: PloS One
https://read.qxmd.com/read/38687742/hebe-project-healthy-aging-versus-inflamm-aging-the-role-of-physical-exercise-in-modulating-the-biomarkers-of-age-associated-and-environmentally-determined-chronic-diseases-study-protocol
#52
JOURNAL ARTICLE
Francesca Bianchi, Elia Mario Biganzoli, Valentina Bollati, Mario Clerici, Daniela Lucini, Chiara Mandò, Federica Rota
Inflamm-aging refers to the chronic low-grade inflammation that occurs with aging and cellular senescence, and it is linked to various diseases. Understanding the markers involved in inflammation and aging, as well as their interaction with environmental factors and bodily control mechanisms, can provide crucial tools for assessing the resilience (i.e. the ability to adapt and improve) of the human body, particularly in the presence of chronic degenerative conditions or vulnerable life stages, that place the individual and the community to which he belongs in a state of potential fragility...
2024: PloS One
https://read.qxmd.com/read/38687739/association-of-the-bitter-taste-genes-tas2r38-and-ca6-and-breast-cancer-risk-a-case-control-study-of-polish-women-in-poland-and-polish-immigrants-in-usa
#53
JOURNAL ARTICLE
Dorota Łukasiewicz-Śmietańska, Dariusz Godlewski, Elżbieta Nowakowska, Andrzej Szpak, Elżbieta Chabros, Grzegorz Juszczyk, Jadwiga Charzewska, Dorothy Rybaczyk-Pathak
It is known that the perception of bitterness is mediated by type 2 bitter taste receptors (TAS2Rs). However, recent reports have suggested that the carbonic anhydrase 6 (CA6) gene may also influence bitterness sensing. Genetic variants in these genes could influence dietary intake of brassica vegetables, whose increased consumption has been observed in the literature, though inconsistently, to decrease breast cancer (BC) risk. We hypothesized that the estimated odds ratios (ORs) for the association between BC and taster diplotype (PAV/PAV) and/or genotype A/A, will be in the direction of increased BC risk, potentially due to reduced consumption of brassica vegetables...
2024: PloS One
https://read.qxmd.com/read/38687694/deep-multiple-instance-learning-versus-conventional-deep-single-instance-learning-for-interpretable-oral-cancer-detection
#54
COMPARATIVE STUDY
Nadezhda Koriakina, Nataša Sladoje, Vladimir Bašić, Joakim Lindblad
The current medical standard for setting an oral cancer (OC) diagnosis is histological examination of a tissue sample taken from the oral cavity. This process is time-consuming and more invasive than an alternative approach of acquiring a brush sample followed by cytological analysis. Using a microscope, skilled cytotechnologists are able to detect changes due to malignancy; however, introducing this approach into clinical routine is associated with challenges such as a lack of resources and experts. To design a trustworthy OC detection system that can assist cytotechnologists, we are interested in deep learning based methods that can reliably detect cancer, given only per-patient labels (thereby minimizing annotation bias), and also provide information regarding which cells are most relevant for the diagnosis (thereby enabling supervision and understanding)...
2024: PloS One
https://read.qxmd.com/read/38687690/estimation-of-maternal-and-foetal-risk-of-radiation-induced-cancer-from-a-survey-of-computed-tomography-pulmonary-angiography-and-ventilation-perfusion-lung-scanning-for-diagnosing-pulmonary-embolism-during-pregnancy
#55
JOURNAL ARTICLE
Donald McLean, Olivia Delfino, Marie Vozzo, Rachael Moorin
INTRODUCTION: While there are many papers on maternal and foetal radiation doses from computed tomography pulmonary angiography (CTPA) and ventilation/perfusion (V/Q) lung scanning examinations for diagnosing pulmonary embolism in pregnant patients, few have used clinical data to examine the patient lifetime attributable risk (LAR) of different cancer types. This paper aims to estimate the cancer risk from maternal radiation doses from CTPA and V/Q examinations and associated foetal doses...
April 30, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38687687/the-efficacy-of-coaxial-percutaneous-iodine-125-seed-implantation-combined-with-arterial-infusion-chemotherapy-for-advanced-pancreatic-cancer-a%C3%A2-randomized-clinical-trial
#56
JOURNAL ARTICLE
HongXiang Yao, Ying ZhuGe, ShiXiang Jin, ShuiBing Chen, HengYiTing Zhang, Dong Zhang, ZhiGang Chen
BACKGROUND: This study aimed to evaluate the clinical efficacy of coaxial percutaneous Iodine-125 (125 I) seed implantation in combination with arterial infusion chemotherapy for the treatment of advanced pancreatic cancer (PC) through a randomized controlled trial. METHODS: A total of 101 patients with advanced PC were randomized into two groups: control group treated with systemic intravenous chemotherapy and experimental group that received 125 I seed implantation in combination with arterial infusion chemotherapy...
April 30, 2024: International Journal of Radiation Biology
https://read.qxmd.com/read/38687678/loss-of-tumor-suppressor-tmem127-drives-ret-mediated-transformation-through-disrupted-membrane-dynamics
#57
JOURNAL ARTICLE
Timothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, Michael G Sugiyama, Larissa C B Oliveira, Aisha N Rekab, Mathieu J F Crupi, Rebecca Cabral-Dias, Qianjin Guo, Patricia L M Dahia, Douglas S Richardson, Costin N Antonescu, Lois M Mulligan
Internalization from the cell membrane and endosomal trafficking of receptor tyrosine kinases (RTKs) are important regulators of signaling in normal cells that can frequently be disrupted in cancer. The adrenal tumor pheochromocytoma (PCC) can be caused by activating mutations of the rearranged during transfection (RET) receptor tyrosine kinase, or inactivation of TMEM127, a transmembrane tumor suppressor implicated in trafficking of endosomal cargos. However, the role of aberrant receptor trafficking in PCC is not well understood...
April 30, 2024: ELife
https://read.qxmd.com/read/38687670/a-colorectal-coordinate-driven-method-for-colorectum-and-colorectal-cancer-segmentation-in-conventional-ct-scans
#58
JOURNAL ARTICLE
Lisha Yao, Yingda Xia, Zhihong Chen, Suyun Li, Jiawen Yao, Dakai Jin, Yanting Liang, Jiatai Lin, Bingchao Zhao, Chu Han, Le Lu, Ling Zhang, Zaiyi Liu, Xin Chen
Automated colorectal cancer (CRC) segmentation in medical imaging is the key to achieving automation of CRC detection, staging, and treatment response monitoring. Compared with magnetic resonance imaging (MRI) and computed tomography colonography (CTC), conventional computed tomography (CT) has enormous potential because of its broad implementation, superiority for the hollow viscera (colon), and convenience without needing bowel preparation. However, the segmentation of CRC in conventional CT is more challenging due to the difficulties presenting with the unprepared bowel, such as distinguishing the colorectum from other structures with similar appearance and distinguishing the CRC from the contents of the colorectum...
April 30, 2024: IEEE Transactions on Neural Networks and Learning Systems
https://read.qxmd.com/read/38687639/langerhans-cell-histiocytosis-nacho-update-on-progress-chaos-and-opportunity-on-the-path-to-rational-cures
#59
REVIEW
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle Hermiston, Michael Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen
Langerhans cell histiocytosis (LCH) is a myeloid neoplastic disorder characterized by lesions with CD1a-positive/Langerin (CD207)-positive histiocytes and inflammatory infiltrate that can cause local tissue damage and systemic inflammation. Clinical presentations range from single lesions with minimal impact to life-threatening disseminated disease. Therapy for systemic LCH has been established through serial trials empirically testing different chemotherapy agents and durations of therapy. However, fewer than 50% of patients who have disseminated disease are cured with the current standard-of-care vinblastine/prednisone/(mercaptopurine), and treatment failure is associated with long-term morbidity, including the risk of LCH-associated neurodegeneration...
April 30, 2024: Cancer
https://read.qxmd.com/read/38687638/discovery-of-llc0424-as-a-potent-and-selective-in-vivo-nsd2-protac-degrader
#60
JOURNAL ARTICLE
Lianchao Liu, Abhijit Parolia, Yihan Liu, Caiyun Hou, Tongchen He, Yuanyuan Qiao, Sanjana Eyunni, Jie Luo, Chungen Li, Yongxing Wang, Fengtao Zhou, Weixue Huang, Xiaomei Ren, Zhen Wang, Arul M Chinnaiyan, Ke Ding
Nuclear receptor-binding SET domain-containing 2 (NSD2), a methyltransferase that primarily installs the dimethyl mark on lysine 36 of histone 3 (H3K36me2), has been recognized as a promising therapeutic target against cancer. However, existing NSD2 inhibitors suffer from low activity or inferior selectivity, and none of them can simultaneously remove the methyltransferase activity and chromatin binding function of NSD2. Herein we report the discovery of a novel NSD2 degrader LLC0424 by leveraging the proteolysis-targeting chimera technology...
April 30, 2024: Journal of Medicinal Chemistry
keyword
keyword
84465
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.